South African Tuberculosis Vaccine Initiative

948 papers and 28.5k indexed citations i.

About

In recent decades, authors affiliated with South African Tuberculosis Vaccine Initiative have published 948 papers, which have received a total of 28.5k indexed citations. Scholars at this organization have produced 411 papers in Infectious Diseases, 330 papers in Epidemiology and 185 papers in Immunology on the topics of Tuberculosis Research and Epidemiology (312 papers), Mycobacterium research and diagnosis (132 papers) and Immunodeficiency and Autoimmune Disorders (84 papers). Their work is cited by papers focused on Infectious Diseases (12.1k citations), Epidemiology (9.0k citations) and Immunology (6.8k citations). Authors at South African Tuberculosis Vaccine Initiative collaborate with scholars in South Africa, United States and United Kingdom and have published in prestigious journals including Nature, Cell and New England Journal of Medicine. Some of South African Tuberculosis Vaccine Initiative's most productive authors include Willem A. Hanekom, Thomas J. Scriba, Gregory Hussey, Mark Hatherill, Naomi Levitt, Christopher H. Trisos, Lara Fairall, Hassan Mahomed, Mark New and Charles Shey Wiysonge.

In The Last Decade

Fields of papers published by authors at South African Tuberculosis Vaccine Initiative

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with South African Tuberculosis Vaccine Initiative at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with South African Tuberculosis Vaccine Initiative at the time of their publication.

Countries citing scholars working at South African Tuberculosis Vaccine Initiative

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at South African Tuberculosis Vaccine Initiative. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at South African Tuberculosis Vaccine Initiative with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites South African Tuberculosis Vaccine Initiative more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025